ne of the listed companies, Indo-BAngla Phramaceuticals Ltd, discloses its financial reports for the third quarter, (January – March 23). This source is known from DSE.
The company’s earnings per share (EPS) of Tk 0.01 paisa in Q3 of the current financial year. EPS was Tk 0.12 paisa during the same period last year.
NAV per share was Tk. 13.99 as on March 31, 2023.
Share this
